Secure shopping
Healthcare and pharma
The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary usꦦe, medical equipment and relat♕ed supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
The pharmaceutical sector in the Czech Republic generated a gross value added (GVA) of CZK 18.9bn in 2016, up by 8.2% y/y in real terms.🔯 It acco🍎unted for 0.44% of the total GVA in the economy in 2016. The sector employed 9,438 workers. Total ...
极速赛车168开奖官网开奖:View more details
In 2015, the total Hungarian healthcare expenditure amounted to HUF 2,373.4bn, or ඣ7.04% of GDP. Public financing schemes made up 67.1% of the healthcare sp꧙ending. By regional standards, the Hungarian health spending as a percentage of GDP is high, ...
极速赛车168开奖官网开奖:View more details
The Russian healthcare and pharmaceutical sector is suffering under the impact of ongoing recession in the Russian economy and depressed domestic demand. The heܫalth🍸care system is in dire need of financing as lower oil prices and a sharply devalued ...
极速赛车168开奖官网开奖:View more details
The Czech pharmaceutical sector is very🀅 attractive for international pharmaceutical manufacturers due to the favourable cost-efficiency ratio. The pharmaceutical sector generated a GVA of CZK 17.9bn in 2015, accounting for 0.4% of the total GVA. ...
极速赛车168开奖官网开奖:View more details